Chemotherapy in Patients Older Than or Equal to 75 Years with Advanced Non Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Kim, Seung [1 ]
Shin, Sang [1 ]
Park, Kyong [1 ]
Oh, Sang [1 ]
Seo, Jae [1 ]
Kim, Jun [1 ]
Kim, Yeul [1 ]
机构：
[1] Korea Univ, Coll Med, Dept Hematol Oncol, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S396 / S396
页数：1
相关论文
共 50 条
  • [41] Observing who performance status of patients undergoing chemotherapy for advanced non-small cell lung cancer (NSCLC)
    van den Borne, Ben
    Bischoff, Helge G.
    Langer, Frank
    Leschinger, Monika, I
    Moneley, Ciara
    Pimentel, Francisco
    Riska, Henrik
    Szczepura, Ala
    Thatcher, Nicholas
    Thomas, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S454 - S455
  • [42] Weekly Paclitaxel as Third Line Chemotherapy in Elderly Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
    Belloni, P.
    Cozzi, C.
    Zannier, F.
    Corradini, G.
    Candido, P.
    Della Torre, S.
    Toniolo, D.
    Fariciotti, A.
    Vismara, A.
    Bollina, R.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S538 - S538
  • [43] Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)
    Pereira, JR
    Martins, SJ
    Nikaedo, SM
    Ikari, FK
    BMC CANCER, 2004, 4 (1)
  • [44] Palliative chemotherapy (QT) and prognostic factors in elderly patients with advanced non-small Cell lung cancer (NSCLC)
    Zotano, AG
    Ariño, LP
    Saera, JM
    Abad, LP
    Lorenzo, JP
    Ortiz, AG
    Beveridge, RD
    Huerta, AS
    Salcedo, JM
    LUNG CANCER, 2005, 49 : S246 - S246
  • [45] Chemotherapy is not superior to erlotinib in pretreated patients with advanced non-small cell lung cancer (NSCLC): A retrospective study
    Neumair, P.
    Joos, L.
    Warschkow, R.
    Ess, S.
    Hitz, F.
    Frueh, M.
    Brutsche, M. H.
    Baty, F.
    Krahenbuhl, S.
    Jorger, M.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S131 - S131
  • [46] Is the platinum-based chemotherapy necessary for elderly patients with advanced non-small cell lung cancer (NSCLC)?
    Daga, H.
    Takeda, K.
    Kiyota, H.
    Tokunaga, S.
    Nanjo, S.
    Sumitani, M.
    Shoji, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] Third-line chemotherapy with gemcitabine or docetaxel in patients with advanced non-small cell lung cancer (NSCLC).
    Morgensztern, D
    Lim, WT
    Subramanian, J
    Viswanathan, A
    Govindan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 694S - 694S
  • [48] What is the place of clinical variables in advanced non-small cell lung cancer (NSCLC) patients treated with chemotherapy?
    Berhoune, M.
    Fabre-Guillevin, E.
    Banu, E.
    Scotte, F.
    Bonan, B.
    Medioni, J.
    Cojocarasu, O.
    Rideller, K.
    Ayllon, J.
    Levy, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC)
    José Rodrigues Pereira
    Sandro J Martins
    Sueli M Nikaedo
    Flora K Ikari
    BMC Cancer, 4
  • [50] Immunotherapy in elderly patients (≥ 75 yrs) with advanced non-small cell lung cancer (NSCLC): A multicenter Italian experience
    Luciani, A.
    Toschi, L.
    Fava, S.
    Cortinovis, D.
    Filipazzi, V.
    Tuzi, A.
    Marra, A.
    Rossi, S.
    Rossi, A.
    Blasi, M.
    Violati, M.
    Sala, L.
    Agustoni, F.
    Bidoli, P.
    Zonato, S.
    Ferrari, D.
    ANNALS OF ONCOLOGY, 2018, 29
12345